Clostridium Difficile Vaccine Safety, Tolerability, and Immunogenicity Study in Japanese Adults

NCT02725437 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Clostridium Difficile Associated Disease

Interventions

BIOLOGICAL: Clostridium difficile Vaccine
BIOLOGICAL: Placebo

Sponsor

Pfizer